MTLS · Materialise NV — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on MTLS. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About MTLS · Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Live Quote
HOLD (score +1) · 12-1 mom 5.1% · RSI 55.7 · above_both · -5.5% from high
Targets blend Wall Street consensus (3 analysts: low $6.56 / mean $8.04 / high $9.65) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Materialise is a Belgian software + 3D printing services company operating across Medical (3D-printed surgical guides/implants), Software (MAGICS CAD/CAM platform licensing), and Manufacturing segments. The Q1 2026 earnings print (May 7, 2026) was strong — €66.3M revenue flat YoY but net profit of €1.82M vs loss a year ago, adjusted EBITDA up 31% to €8M. Gross margin expanded to 57.2%. However, the top line has been essentially flat for multiple quarters and FY2025 showed no revenue growth (-0.2% YoY). The company is actively executing a €30M share buyback program (511K shares repurchased through Q1), which is accretive but modest given its ~€385M market cap. The stock has rallied from $4.80 52-week lows to near $7, within ~5.6% of the 52-week high at time of investigation. No insider open-market purchases were detected (edgar_form4_insiders returned zero records). Options data is sparse and IV is extremely low — no income premium exists. There is a Zacks 'undervalued' article circulating but it is not supported by hard re-rating catalysts in the next 3-12 months.